In the TME, MDSCs, by production of VEGF, FGF2, Bv8, and matrix metalloprotease (MMP) 9 (MMP9), can trigger and sustain tumor angiogenesis (44, 133) (Figure 3). The gene discussed is MMP9; the disease is neoplasm.